These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3520951)

  • 1. A possible split of antigen DQw1 identified by antiserum T3516.
    Satake M; Matsuki K; Yabe T; Suzuki M; Juji T
    Tissue Antigens; 1986 Mar; 27(3):155-62. PubMed ID: 3520951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assignment of determinants recognized by human alloantisera to HLA-D-subregion molecules by a lysostrip technique.
    Nuñez G; Stastny P
    Tissue Antigens; 1986 Apr; 27(4):185-95. PubMed ID: 2425451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of class II HLA antigens (HLA-DR, DQW1, DQW3) in normal skin and cutaneous pathology].
    Gomes M; Schmitt D; Dezutter-Dambuyant C; Capra JD; Thivolet J
    Pathol Biol (Paris); 1986 Mar; 34(3):157-64. PubMed ID: 3517784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecules recognized by anti-MT2 alloantisera and anti-MT2-like (DRw52) monoclonal antibodies are different.
    Schiffenbauer J; Bono C; Schwartz BD
    Hum Immunol; 1985 Apr; 12(4):223-33. PubMed ID: 3872866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A human-human hybridoma (Tr7E2) producing cytotoxic antibody to HLA-DQw1.
    Hansen T; Kolstad A; Mathisen G; Hannestad K
    Hum Immunol; 1987 Dec; 20(4):307-20. PubMed ID: 2449413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
    Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
    J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the expression of three different BoLA-class II molecules on the bovine BL-3 cell line: determination of a non-DR non-DQ gene product.
    Ababou A; Goyeneche J; Davis WC; Lévy D
    J Leukoc Biol; 1994 Aug; 56(2):182-6. PubMed ID: 7520928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of seven new monoclonal antibodies against human DR, DR + DP and DQ1 + DQ3 antigens.
    Horejsí V; Nĕmec M; Angelisová P; Kristofová H; Gorga JC; Hilgert I
    Tissue Antigens; 1986 Nov; 28(5):288-97. PubMed ID: 2435017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ontogenic and functional implications of the differential expression of HLA-DQ antigens on leukemic cells.
    Navarrete C; Fernandez N; Alonso MC; Festenstein H
    Hum Immunol; 1986 May; 16(1):52-68. PubMed ID: 3519548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NO1: an HLA-DQw1-associated determinant present on loss mutants not expressing DQw1.
    Ohta N; Bach FH
    Hum Immunol; 1986 May; 16(1):91-9. PubMed ID: 2423488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
    Clement LT; Tedder TF; Gartland GL
    J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
    Pesando JM; Graf L
    J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies directed against HLA-DR gene products exhibit the CYNAP phenomenon.
    Gebel HM; Oldfather JW; Karr RW; Fuller TC; Rodey GE
    Tissue Antigens; 1984 Mar; 23(3):135-40. PubMed ID: 6427971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel HLA class II alloantigen detected by an alloantiserum TK2.
    Matsuki K; Juji T; Satake M
    Hum Immunol; 1987 Mar; 18(3):247-56. PubMed ID: 3494716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR antigen grouping by use of monoclonal antibody probes: expansion of known groups, and mechanism of cytotoxicity blocking.
    Taylor CG; Grumet FC
    J Immunol; 1982 Mar; 128(3):1489-90. PubMed ID: 7035566
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations.
    Nuñez G; Giles RC; Ball EJ; Hurley CK; Capra JD; Stastny P
    J Immunol; 1984 Sep; 133(3):1300-6. PubMed ID: 6611370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Ia antigen expression by autologous human erythroid and B lymphoblastoid cell lines.
    Symington FW; Levine F; Braun M; Brown SL; Erlich HA; Torok-Storb B
    J Immunol; 1985 Aug; 135(2):1026-32. PubMed ID: 3874223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of the HLA-DQ system by the complement fixation test on lymphocytes stimulated by phytohemagglutinin. Existence of HLA-DQX allele(s)].
    Chidiac A; Colombani M; Lepage V; Raffoux C; Sansonetti N; Colombani J
    Rev Fr Transfus Immunohematol; 1986 Apr; 29(2):65-79. PubMed ID: 3092321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.